Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.55 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.45 |
| ▸ | TRPA1 | O75762 | 3/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1453002 | 1.00 | TSHR (0.55) | TSHRABCC4MAPTALDH1A1TRPA1 | |
| SCHEMBL129429 | 1.00 | TSHR (0.55) | TSHRABCC4MAPTALDH1A1TRPA1 | |
| SCHEMBL130045 | 1.00 | TSHR (0.55) | TSHRABCC4MAPTALDH1A1TRPA1 | |
| SCHEMBL130032 | 1.00 | TSHR (0.55) | TSHRABCC4MAPTALDH1A1TRPA1 | |
| SCHEMBL20503164 | 1.00 | TSHR (0.55) | TSHRABCC4MAPTALDH1A1TRPA1 | |
| SCHEMBL127964 | 1.00 | TSHR (0.55) | TSHRABCC4MAPTALDH1A1TRPA1 | |
| SCHEMBL1454994 | 1.00 | TSHR (0.55) | TSHRABCC4MAPTALDH1A1TRPA1 | |
| SCHEMBL1452859 | 1.00 | TSHR (0.55) | TSHRABCC4MAPTALDH1A1TRPA1 | |
| SCHEMBL1005861 | 1.00 | TSHR (0.55) | TSHRABCC4MAPTALDH1A1TRPA1 | |
| SCHEMBL131546 | 1.00 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 388 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4387607-A1 | NANOPARTICLE COMPOSITIONS CONTAINING SUGAR FUNCTIONALIZED NUCLEIC ACID CARRIERS | Tiba Biotech LLC (US) | 2024-06-26 | — | — | EP | claimed |
| CN-117897152-A | Nanoparticle compositions containing sugar-functionalized nucleic acid vectors | 蒂巴生物技术有限公司 | 2024-04-16 | — | — | CN | claimed |
| US-20240093238-A1 | NANOPARTICLE COMPOSITIONS CONTAINING SUGAR FUNCTIONALIZED NUCLEIC ACID CARRIERS | TIBA BIOTECH LLC (US) | 2024-03-21 | — | — | US | claimed |
| US-11859201-B2 | Nanoparticle compositions containing sugar functionalized nucleic acid carriers | TIBA BIOTECH LLC (US) | 2024-01-02 | — | — | US | claimed |
| US-20230100837-A1 | NANOPARTICLE COMPOSITIONS CONTAINING SUGAR FUNCTIONALIZED NUCLEIC ACID CARRIERS | TIBA BIOTECH LLC (US) | 2023-03-30 | — | — | US | claimed |
| WO-2023022926-A1 | NANOPARTICLE COMPOSITIONS CONTAINING SUGAR FUNCTIONALIZED NUCLEIC ACID CARRIERS | TIBA BIOTECH LLC (US) | 2023-02-23 | — | — | WO | claimed |
| EP-4132586-A1 | CARRIERS FOR EFFICIENT NUCLEIC ACID DELIVERY | Tiba Biotech LLC (US) | 2023-02-15 | — | — | EP | claimed |
| CN-109232388-B | Synthetic method of natural alpha-glucosidase inhibitor Penasulfate A | 江汉大学 | 2021-11-16 | — | — | CN | claimed |
| EP-3898942-A1 | NANOPARTICLE COMPOSITIONS FOR EFFICIENT NUCLEIC ACID DELIVERY AND METHODS OF MAKING AND USING THE SAME | Tiba Biotech LLC (US) | 2021-10-27 | — | — | EP | claimed |
| US-10894932-B2 | Fabric care composition comprising glyceride copolymers | THE PROCTER & GAMBLE COMPANY (US) | 2021-01-19 | — | — | US | claimed |
| US-10265249-B2 | Fibrous structures comprising glyceride copolymers | THE PROCTER & GAMBLE COMPANY (US) | 2019-04-23 | — | — | US | claimed |
| US-20180161474-A1 | ABSORBENT ARTICLES COMPRISING GLYCERIDE COPOLYMERS | THE PROCTER & GAMBLE COMPANY | 2018-06-14 | — | — | US | claimed |
| WO-2018063781-A1 | HAIR CARE COMPOSITIONS COMPRISING GLYCERIDE COPOLYMERS | THE PROCTER & GAMBLE COMPANY (US) | 2018-04-05 | — | — | WO | claimed |
| US-20180092820-A1 | HAIR CARE COMPOSITIONS COMPRISING GLYCERIDE COPOLYMERS | THE PROCTER & GAMBLE COMPANY | 2018-04-05 | — | — | US | claimed |
| US-20180094388-A1 | Fibrous Structures Comprising a Surface Softening Composition | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2018-04-05 | — | — | US | claimed |
| WO-2018063774-A1 | HAIR CARE COMPOSITIONS COMPRISING A GEL MATRIX AND GLYCERIDE COPOLYMERS | THE PROCTER & GAMBLE COMPANY (US) | 2018-04-05 | — | — | WO | claimed |
| US-20180092825-A1 | HAIR CARE COMPOSITIONS COMPRISING A GEL MATRIX AND GLYCERIDE COPOLYMERS | THE PROCTER & GAMBLE COMPANY | 2018-04-05 | — | — | US | claimed |
| US-20180085288-A1 | FIBROUS STRUCTURES COMPRISING GLYCERIDE COPOLYMERS | THE PROCTER & GAMBLE COMPANY | 2018-03-29 | — | — | US | claimed |
| WO-2018034664-A1 | FABRIC CARE COMPOSITION COMPRISING GLYCERIDE COPOLYMERS | THE PROCTER & GAMBLE COMPANY (US) | 2018-02-22 | — | — | WO | claimed |
| US-20180051235-A1 | FABRIC CARE COMPOSITION COMPRISING GLYCERIDE COPOLYMERS | THE PROCTER & GAMBLE COMPANY | 2018-02-22 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180092820-A1 | HAIR CARE COMPOSITIONS COMPRISING GLYCERIDE COPOLYMERS | SGMS2, SGMS1, PHOSPHO1 | TSHR 4200/4885ABCC4 2600/4885MAPT 2089/4885 |
| US-10265249-B2 | Fibrous structures comprising glyceride copolymers | FIBP, PHOSPHO1, FN1 | TSHR 4687/4885ABCC4 1835/4885MAPT 524/4885 |
| US-20230100837-A1 | NANOPARTICLE COMPOSITIONS CONTAINING SUGAR FUNCTIONALIZED NUCLEIC ACID CARRIERS | TLR9, TLR3, TSG101 | TSHR 2118/4885ABCC4 1977/4885MAPT 1205/4885 |
| US-20180085288-A1 | FIBROUS STRUCTURES COMPRISING GLYCERIDE COPOLYMERS | FIBP, PHOSPHO1, FN1 | TSHR 4687/4885ABCC4 1835/4885MAPT 524/4885 |
| US-20180092825-A1 | HAIR CARE COMPOSITIONS COMPRISING A GEL MATRIX AND GLYCERIDE COPOLYMERS | CUTA, OTC, POLR1C | TSHR 4636/4885ABCC4 2940/4885MAPT 1272/4885 |
| US-20240093238-A1 | NANOPARTICLE COMPOSITIONS CONTAINING SUGAR FUNCTIONALIZED NUCLEIC ACID CARRIERS | TLR9, TLR3, TSG101 | TSHR 2118/4885ABCC4 1977/4885MAPT 1205/4885 |
| US-11859201-B2 | Nanoparticle compositions containing sugar functionalized nucleic acid carriers | TLR9, TLR3, TSG101 | TSHR 2118/4885ABCC4 1977/4885MAPT 1205/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.